Similar Items: Evaluation of mycobacterium smegmatis infected d THP-1 macrophages as a model to assess host directed therapy: using apoptotic agents as repurposed anti-tuberculosis drug leads.
- Targeted depletion of RibF, a putative bifunctional FAD synthetase/ flavokinase in Mycobacterium smegmatis using CRISPR interference
- Pro–apoptotic iron oxide nanosystems as selective anti – TB drugs
- Gene expression changes in macrophages infected with pathogenic M. tuberculosis and non-pathogenic M. smegmatis and M. bovis BCG
- IL-4/IL-13-inducible lincRNA-MIR99AHG regulates macrophage polarization and promotes intracellular survival of Mycobacterium tuberculosis
- The effect of environmental conditions on growth and phenotype switching in Mycobacterium smegmatis
- Characterization of mechanisms leading to Mycobacterium tuberculosis strain diversity
Author: Mavumengwana, Vuyo
- The antimycobacterial activity of phytocannabinoids
- Ferrocene sulfonyl derivatives as antimycobacterials
- Investigation of the antimycobacterial activity of fungal endophytes and their magnetic dendrimer stabilized nanoparticles against mycobacteria
- Evaluation of mycobacterium smegmatis infected d THP-1 macrophages as a model to assess host directed therapy: using apoptotic agents as repurposed anti-tuberculosis drug leads.
- Metallophiles as sources of antimycobacterial agents
- Mycobacterium tuberculosis metallomics